Experiments

Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).

• Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell states.

  PMID 42020604 · PMC13175895 · Nature genetics · 2026 · 8 claims · 6 setups

  Full-text index only

  A generalizable, network-based framework was established to systematically identify combination therapies targeting complementary coexisting tumor cell states

  malignant eight patient-derived dmg single-cell pooled plate-seq

• Single-Cell Computational Frameworks for Quantifying BET Bromodomain Inhibitor Resistance and Screening Re-Sensitizer Drugs in Triple-Negative Breast Cancer.

  PMID 41933924 · PMC13205605 · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026 · 7 claims · 8 setups

  Full-text index only

  Ferroptosis inhibition, marked by upregulation of suppressors (e.g., FTH1, GPX4) and downregulation of drivers, underlies the evolution of JQ1 resistance in TNBC cells

  sum159 sum149 six lincs scrna-seq bulk cck8

• MECP2 mutations rewire human ESC fate and bias cortical lineage commitment.

  PMID 42030940 · PMC13163216 · Stem cell reports · 2026 · 8 claims · 8 setups

  Full-text index only

  MECP2 mutations induce an early naïve-like transcriptional drift in human ESCs, marked by upregulation of ZFP42/REX1 and other naïve-enriched markers

  isogenic undifferentiated 3-month bulk bulk single-cell single-nucleus